Application 202024
- Type
- ANDA
- Sponsor
- AMNEAL PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GABAPENTIN | GABAPENTIN | SOLUTION;ORAL | 250MG/5ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 17856-0698 | Gabapentin | Gabapentin | ATLANTIC BIOLOGICALS CORP. | ANDA | Current |
| 65162-698 | Gabapentin | Gabapentin | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-698 | Gabapentin | Gabapentin | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-698 | Gabapentin | Gabapentin | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-698 | Gabapentin | Gabapentin | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-698 | Gabapentin | Gabapentin | Amneal Pharmaceuticals LLC | ANDA | Current |